Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 21:12:623979.
doi: 10.3389/fphar.2021.623979. eCollection 2021.

Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey

Affiliations

Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey

Daniel Perkins et al. Front Pharmacol. .

Abstract

Ayahuasca is a traditional plant decoction containing N,N-dimethyltryptamine (DMT) and various β-carbolines including harmine, harmaline, and tetrahydroharmine, which has been used ceremonially by Amazonian Indigenous groups for healing and spiritual purposes. Use of the brew has now spread far beyond its original context of consumption to North America, Europe, and Australia in neo-shamanic settings as well as Christian syncretic churches. While these groups have established their own rituals and protocols to guide use, it remains unknown the extent to which the use of traditional or non-traditional practices may affect drinkers' acute experiences, and longer term wellbeing and mental health outcomes. Hence, this study aimed to provide the first detailed assessment of associations between ceremony/ritual characteristics, additional support practices, motivations for drinking, and mental health and wellbeing outcomes. The paper uses data from a large cross-sectional study of ayahuasca drinkers in more than 40 countries who had used ayahuasca in various contexts (n = 6,877). It captured detailed information about participant demographics, patterns and history of ayahuasca drinking, the setting of consumption, and ritualistic practices employed. Current mental health status was captured via the Kessler 10 psychological distress scale and the mental health component score of the SF-12 Health Questionnaire, while reported change in prior clinically diagnosed anxiety or depression (n = 1276) was evaluated using a (PGIC) Patient Global Impression of Change tool. Various intermediate outcomes were also assessed including perceived change in psychological wellbeing, number of personal self-insights attained, and subjective spiritual experience measured via the spirituality dimension of the Persisting Effects Questionnaire (PEQ) and Short Index of Mystical Orientation. Regression models identified a range of significant associations between set and setting variables, and intermediate and final mental health and wellbeing outcomes. A generalized structural equation model (GSEM) was then used to verify relationships and associations between endogenous, mediating and final outcome variables concurrently. The present study sheds new light on the influence of ceremonial practices, additional supports and motivations on the therapeutic effects of ayahuasca for mental health and wellbeing, and ways in which such factors can be optimized in naturalistic settings and clinical studies.

Keywords: adverse effects; ayahuasca; mental health; psychedelic therapy; set and setting.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Analysis framework and data items utilized.
FIGURE 2
FIGURE 2
Associations between motivations, ceremony characteristics and additional supports, and intermediate and final mental health outcomes. MH diagnoses, number of lifetime mental health diagnoses; Preparation, preparation activities accompanying ayahuasca use (per Table 1); Relig/spir couns., religious or spiritual counseling; Times drunk, number of times ayahuasca has been drunk; Trad. country, all Amazonian countries where ayahuasca has been used traditionally by indigenous groups except Brazil (Peru, Ecuador, Colombia, Bolivia, and Venezuela). Black color is positively associated, and gray color is negatively associated. All paths shown are significant at p < 0.001, other than “Self-knowledge → Community,” “Experiential → Community,” “Relig/spir couns → Integ diffs,” “Therapeutic → SIMO,” “Religious → SIMO,” “Fasting → SIMO,” and “Yoga/tai-chi etc → SIMO,” all p < 0.01; and “Fasting → Self-insight,” “Support and safety → Self-insight,” “Non-traditional → Integ diffs” and “Times drunk → Integ diffs” all p < 0.05. “Religious → Integ diffs,” and “Non-traditional → Community” was not significant.
FIGURE 3
FIGURE 3
Summary of key findings.

Similar articles

Cited by

References

    1. Andritzky W. (1989). Sociopsychotherapeutic functions of ayahuasca healing in Amazonia. J. Psychoact. Drugs 21 (1), 77–89. 10.1080/02791072.1989.10472145 - DOI - PubMed
    1. Barbosa P. C. R., Strassman R. J., da Silveira D. X., Areco K., Hoy R., Pommy J., et al. (2016). Psychological and neuropsychological assessment of regular hoasca users. Compr. Psychiatry 71, 95–105. 10.1016/j.comppsych.2016.09.003 - DOI - PubMed
    1. Beyer S. (2009). Singing to the plants: a guide to Mestizo shamanism in the upper Amazon. Albuquerque, NM: University of New Mexico Press.
    1. Bouso J. C., González D., Fondevila S., Cutchet M., Fernández X., Ribeiro Barbosa P. C., et al. (2012). Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study. PLoS One 7 (8), e42421. 10.1371/journal.pone.0042421 - DOI - PMC - PubMed
    1. Breeksema J. J., Niemeijer A. R., Krediet E., Vermetten E., Schoevers R. A. (2020). Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies. CNS Drugs 34 (9), 925–946. 10.1007/s40263-020-00748-y - DOI - PMC - PubMed

LinkOut - more resources